Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Opinion in Nephrology and Hypertension is Scopus-indexed (Q1, CiteScore 4.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 1062-4821Verify ISSN ↗1473-6543Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Nephrology | 19 / 88 | 78th | Q1 |
| Internal Medicine | 61 / 179 | 66th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1992–present, best quartile Q1, CiteScore 4.9.
Current Opinion in Nephrology and Hypertension is Q1 in Nephrology (rank 19 of 88) and Q2 in Internal Medicine (rank 61 of 179), by CiteScore 2025.
Current Opinion in Nephrology and Hypertension is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.9, which places it in quartile Q1 at the 78th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.939, quartile Q1, with an H-index of 113.
Current Opinion in Nephrology and Hypertension is published by Lippincott Williams and Wilkins. Its print ISSN is 1062-4821 and its online ISSN is 1473-6543.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Opinion in Nephrology and Hypertension has an h-index of 125 and a 2-year mean of 3.17 citations per paper (OpenAlex). Its Scopus CiteScore is 4.9, quartile Q1. On 2-year citations it ranks #9 of 87 Scopus journals in Nephrology.
Current Opinion in Nephrology and Hypertension published 88 papers in 2025; its busiest recent year was 2019 with 98. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from United States (52.3%), United Kingdom (11.8%) and Türkiye (4.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.